About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,994 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,994 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4161-4180 of 7,994 trials

CompletedConcordance of Inivata Liquid Biopsy With Standard of Care Tissue TestingThe aim of this study is to evaluate the performance of Inivata liquid biopsy analysis compared with standard tissue biopsy analysis for detection of genomic alterations in…NCT02906852·Mission Hills, California and 34 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

UnknownA Study of HLX07 + HLX10 With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line sqNSCLCThe purpose of this study is to evaluate the clinical efficacy and safety of HLX07 In Combination with HLX10 with or without Chemotherapy versus HLX10 with Chemotherapy in First…NCT04976647·Guangzhou, Guangdong

TerminatedA Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung CancerThe purpose of this study is to determine if adding ASA404 to docetaxel chemotherapy makes the cancer treatment more effective in patients with locally advanced or metastatic…NCT00738387·Huntsville, Alabama and 161 others

TerminatedThe ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant SettingThe goal of this clinical research study is to learn if it is tolerable for patients with NSCLC to receive afatinib before surgery. The safety of this drug will also be studied.NCT02271906·Houston, Texas

UnknownEfficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung CancerLung cancer is one of the most common causes of cancer death worldwide.NCT04840004·Adana and 3 others

WithdrawnA Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung CancerThe purpose of this trial is to measure ALA-induced fluorescence in both normal and malignant tissue.NCT01611584·Lebanon, New Hampshire

TerminatedFunctional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical TrialConcurrent chemoradiotherapy is the standard treatment for locally advanced, unresectable non-small cell lung cancer, but carries a risk of radiation pneumonitis of approximately…NCT02002052·London, Ontario

CompletedBevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R MutationThis is a prospective, single-arm, single-center, phase II trial designed to evaluate the efficacy and safety of bevacizumab combined with a double dose of icotinib as a…NCT05263947·Tianjin, Tianjin Municipality

Not yet recruitingLow-Frequency rTMS for In-Hospital Sleep Disturbance in Advanced NSCLCThis randomized, double-blind, sham-controlled trial will evaluate whether low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve in-hospital sleep quality…NCT07796438

CompletedErlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung AdenocarcinomaBoth pemetrexed and erlotinib are second-line treatment options for patients with advanced non-small cell lung cancer.NCT01565538·Guangzhou, Guangdong

CompletedA Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerThis multicenter, single-arm study will evaluate the efficacy and safety of Atezolizumab in participants with PD-L1-positive locally advanced or metastatic non-small cell lung…NCT02031458·Gilbert, Arizona and 109 others

TerminatedAn Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization SystemThe goals of this clinical research are to evaluate the outcomes and tumor response for early stage non-small lung cancer (NSCLC) patients undergoing Stereotactic Body Radiation…NCT02067858·Pittsburgh, Pennsylvania

RecruitingA Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCA phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of EPI-326 administered to patients with locally advanced or…NCT07462377·Los Angeles, California and 5 others

CompletedErlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung CancerThis 2 arms study will compare the efficacy and safety of treatment with sequential erlotinib plus docetaxel therapy versus docetaxel alone as second line treatment in patients…NCT01350817·Angers and 29 others

UnknownK-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C MutationThe goal of this interventional study is to learn about the combination of sotorasib and stereotactic radiation therapy (SBRT) in patients with metastatic non-small cell lung…NCT06127940·Stockholm, Solna

Not yet recruitingNeoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLCThe neoadjuvant strategy of immunotherapy combined with chemotherapy has been recommended for resectable or potentially resectable tumors without driver-gene alterations.However…NCT07231575

CompletedA Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)This study will assess the safety and tolerability, and make a preliminary assessment of activity, of a combination of pertuzumab and erlotinib in patients with locally advanced…NCT02507375·Antwerp and 2 others

CompletedA Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung CancerLung cancer tumors become resistant to the first generation epidermal growth factor receptor (EGFR) inhibitors erlotinib or gefitinib by changing and increasing the activity of…NCT01121575·Aurora, Colorado and 9 others

CompletedTrial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung CancerThe primary objective of this trial is to determine the maximum tolerated dose (MTD) and recommended Phase II doses for the combination of BIBW 2992 and cetuximab in patients with…NCT01090011·Aurora, Colorado and 5 others

Not yet recruitingOsimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLCOsimertinib, though a standard first-line treatment for EGFR-mutant advanced NSCLC, shows primary resistance in 10-30% of patients, leading to disease progression within 3-4…NCT06436144

PreviousPage 209 of 400Next